HIGHLIGHTS
- who: Arata Osanami from the University of Wurzburg, Germany have published the research: Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome, in the Journal: (JOURNAL)
- how: The authors described a case history of a patient with TBIR who presented hyperglycemia hyperinsulinemia and Frontiers in Endocrinology Ethics statements Ethical review and approval was not required because this is not a clinical study but a case report in accordance with the local legislation and institutional requirements.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.